More Articles

US guidelines for biosimilars Guidelines | Posted 12/11/2010

Last update: 14 December 2018The regulatory body for approval of medicines in the US is the Food and Drug Administration (FDA).

Hurdles to biosimilars in Asia Biosimilars/General | Posted 12/11/2010

Now that a clear regulatory pathway for marketing biosimilars has been established in Europe, will Asian companies enter the global biosimilars race? Asian manufacturers face the same obstacles as...

Mylan granted US restraining order over sales of paroxetine Pharma News | Posted 12/11/2010

Generics’ giant Mylan Laboratories was granted a US court order in September 2010 prohibiting Apotex, a Canadian pharma company, from selling paroxetine. The order also prohibits GlaxoSmithKline (G...

Pfizer and India-based Biocon make biosimilar insulin deal Biosimilars/News | Posted 08/11/2010

Biocon, India’s largest biotechnology company by revenue and Pfizer—the world’s biggest pharma company—announced on 18 October 2010 that they have entered into a strategic global agreement for the...

UK scraps generic substitution plans Policies & Legislation | Posted 08/11/2010

The UK government has announced that it will not progress with plans to automatically substitute medications with generic drugs in primary care. Health Minister Lord Howe announced the decision on...

Slow response to internet sales of fake pharmaceuticals Generics/General | Posted 08/11/2010

If you are reading this news online, you are surely aware that many sites claim to sell “generic medicines” “without prescription” over the internet. Police and authorities have noticed as well, bu...

Spotlight on Bosnia Pharma News | Posted 08/11/2010

In today’s global business environment, companies battle for position all over the world. Today Bosnia’s pharmaceutical industry is making the headlines, with a battle to invest in the leading comp...

Teva continues to expand Generics/News | Posted 08/11/2010

The world's largest generic pharmaceutical company, Israeli-based Teva Pharmaceutical Industries, is investing Euros 42 million to expand its production plant in Stouffville, Canada. At the same ti...